Farms.com Home   News

Cargill And UFCW 401 Back At The Bargaining Table

The beef sector is hoping to see an agreement reached that will avert a potential lock out at the Cargill meat packing plant at High River.

Negotiators for Cargill and the United Food and Commercial Workers Canada Union Local 401 are back at the bargaining table today.

A report called "No Safe Place" compiled by the Centre for Refugee Studies at York University and the advocacy group Action Dignity focused on conditions faced by employees during COVID at Alberta's meatpacking plants.

Action Dignity's website notes Cargill workers want to see :

- Increased wages for all, including full retroactive pay. (The company reportedly ended its extra pandemic pay for workers last year.)
- Increased signing bonus
- Fair ways to monitor line speeds
- Limitations on benefit costs and co-pays
- Increased benefit coverage
- Health and safety improvements
- Sick leave
- Improvements to shift scheduling

Cargill has reportedly exchanged proposals with the union focusing around increased wages, cash bonuses and enhanced employee benefits.

However, workers voted 98% against Cargill's offer last week.

That resulted in the company serving notice that if contract talks (which begin Nov 30) are unsuccessful it will lock out more than 2000 workers at the plant starting on Monday, December 6th.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.